Showing results (291-300 of 376) with videos related to

Sort By:
Pageof 38
Journal of the International AIDS Society|November 15, 2014
ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR studyDaniel Podzamczer, Nerea Rozas, Pere Domingo, et al.
The Journal of Antimicrobial Chemotherapy|August 4, 2023
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravirAna González-Cordón, Lambert Assoumou, Graeme Moyle, et al.
Frontiers in Medicine|July 7, 2023
Cardiovascular events in delayed presentation of HIV: the prospective PISCIS cohort studyRaquel Martín-Iguacel, Mari Carmen Vazquez-Friol, Joaquin Burgos, et al.
AIDS (London, England)|April 2, 2005
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosineAna Barrios, Ana Rendón, Eugenia Negredo, et al.
Scientific Reports|November 2, 2019
IL-7/IL-7R gene variants impact circulating IL-7/IL-7R homeostasis and ART-associated immune recovery statusAndra Ceausu, Esther Rodríguez-Gallego, Joaquim Peraire, et al.
Antiviral Research|February 5, 2014
Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV-HCV coinfected subjectsMiguel Genebat, Francisco Vera, José Hernández-Quero, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2011
Restoration of T cell responses to toxoplasma gondii after successful combined antiretroviral therapy in patients with AIDS with previous toxoplasmic encephalitisMarylène Lejeune, José M Miró, Elisa De Lazzari, et al.
The New England Journal of Medicine|September 12, 2003
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infectionEsteban Martínez, Juan A Arnaiz, Daniel Podzamczer, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2014
Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS)Consuelo Viladés, Xavier Escoté, Miguel López-Dupla, et al.
Current HIV Research|September 28, 2007
HIV-1-infected long-term non-progressors have milder mitochondrial impairment and lower mitochondrially-driven apoptosis in peripheral blood mononuclear cells than typical progressorsJoaquim Peraire, Oscar Miró, Maria Saumoy, et al.
Pageof 38